Clinical Trials Directory

Trials / Completed

CompletedNCT00497432

Hyperbaric Oxygen Treatment in Patients With White Matter Hyperintensities

Hyperbaric Oxygen Treatment In Patients With White Matter Hyperintensities On Magnetic Resonance Imaging and Neurologic Deficits

Status
Completed
Phase
Study type
Observational
Enrollment
20 (actual)
Sponsor
St. Luke's Hospital, Chesterfield, Missouri · Academic / Other
Sex
All
Age
50 Years
Healthy volunteers
Not accepted

Summary

The primary purpose of this study is to assess whether hyperbaric oxygen treatment improves neurological function in patients who exhibit white matter hyperintensities on MRI examination. The secondary goal of this study is to determine if it is possible using MRI to discern a difference in perfusion of central nervous system tissue in regions of white matter hyperintensities after hyperbaric oxygen administration as compared to hyperbaric air.

Detailed description

Consecutively enrolled patients will be assigned to hyperbaric oxygen or hyperbaric air by random number. Physicians supervising the hyperbaric treatments and the treating technicians, the evaluating neurologist, and the interpreter of the MRIs will be blinded regarding patient treatment status. All patients who receive placebo will be offered treatment with hyperbaric oxygen.

Conditions

Timeline

Start date
2007-07-01
Primary completion
2012-09-01
Completion
2012-11-01
First posted
2007-07-06
Last updated
2013-05-31

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00497432. Inclusion in this directory is not an endorsement.